A case of delayed skin necrosis caused by enoxaparin anticoagulation after cervical cancer surgery

A case of delayed skin necrosis caused by enoxaparin anticoagulation after cervical cancer surgery

Low-molecular-weight heparin has multiple advantages of high bioavailability, long half-life, few side effects and convenient use, which has been widely applied in the prevention of lower limb venous thrombosis after gynecologic tumor surgery. However, in clinical practice, partial patients present...

Full description

Bibliographic Details
Main Author:	Li Sijin, He Zeyang, Li Haiying, Wang Xiaojun, Zhou Ying, Li Daocheng
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of New Medicine 2022-02-01
Series:	Xin yixue
Subjects:	\|low-molecular-weight heparin\|enoxaparin\|skin necrosis\|cervical cancer\|low limb venous thrombosis\|post-operation
Online Access:	https://www.xinyixue.cn/fileup/0253-9802/PDF/1646274212743-1820668707.pdf

Similar Items

An unusual case of enoxaparin-induced localized skin necrosis
by: Asmita Kapoor, et al.
Published: (2023-01-01)

Heparin, Enoxaparin, and Mechanical Prophylaxis Utilization Evaluation in DVT Prophylaxis in a Major Teaching Hospital in West of Iran
by: Anali Ali Akbari, et al.
Published: (2021-12-01)

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients
by: Egidio Imbalzano, et al.
Published: (2024-01-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins
by: Natal'ya Mikhaylovna Vorob'eva, et al.
Published: (2011-08-01)

Comparison of the prevalence of venous thromboembolism in patients treated with enoxaparin and heparin: A cross-sectional study in the intensive care unit of Imam Khomeini Hospital in Ahvaz
by: Mohsen Savaie, et al.
Published: (2022-05-01)

Spontaneous Intramuscular Hematoma due to Subcutaneous Enoxaparın
by: Ahmet Gürdal, et al.
Published: (2019-01-01)

Bullous hemorrhagic dermatosis induced by enoxaparin
by: Isa An, et al.
Published: (2017-01-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-04-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-07-01)

Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery
by: Luminita Iliuta, et al.
Published: (2022-08-01)

Once-daily versus twice-daily enoxaparin for the initial treatment of acute deep venous thrombosis: a case–control study
by: Mohamad T Yusuf, et al.
Published: (2019-01-01)

Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects
by: Sumit Saxena, et al.
Published: (2022-08-01)

Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; A clinical trial
by: Fariba Iraji, et al.
Published: (2013-01-01)

The safety of enoxaparine use in elderly with acute myocardial infarction
by: Despotović Nebojša, et al.
Published: (2007-01-01)

Comparing the Effectiveness Results of Heparin and Enoxaparin after Total Hip Artroplasty
by: Hamidreza Arti, et al.
Published: (2013-06-01)

Bemiparin Versus Enoxaparin for Extended Thromboprophylaxis in COVID-19 Patients at High Risk of Venous Thromboembolism
by: Ahmet Can TOPÇU, et al.
Published: (2021-01-01)

Enoxaparina en el tratamiento de la tromboembolia venosa: estudio observacional de práctica clínica habitual
by: Antoni Riera-Mestre, et al.
Published: (2021-04-01)

Comparison of Generic (Rolexan) and Brand (Clexan) Forms of Enoxaparin in Critically Ill Patients: A Cross Over, Open Label, Randomized Prospective Clinical Trial
by: Shadi Ziaie, et al.
Published: (2020-03-01)

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
by: Pieter M.M. De Kesel, et al.
Published: (2020-01-01)

A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
by: Murray R, et al.
Published: (2021-10-01)

Enoxaparin sodium as a drug of choice for the treatment of thrombosis in oncology
by: О. V. Somonova, et al.
Published: (2021-06-01)

Enoxaparin is a low-molecular-weight heparin with a complex chemical structure and various non-anticoagulant properties
by: S K Zyryanov, et al.
Published: (2016-12-01)

Comparison of Enoxaparin versus Heparin among Patients Undergoing Elective Coronary Angiography via Radial Artery Access
by: Reza Kiani, et al.
Published: (2018-01-01)

Enoxaparin-Induced DRESS Syndrome
by: Sophie Ronceray, et al.
Published: (2012-10-01)

Efficacy and Safety of Enoxaparin versus New Oral Anticoagulants to Prevent Venous Thromboembolism after Total Hip Replacement: A Systematic Review and Meta-Analysis
by: Mohammed Farhan A Alfarhan
Published: (2022-01-01)

Prevention of venous thromboembolic events in ischemic stroke
by: Vladimir Anatolyevich Parfenov
Published: (2013-11-01)

Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism
by: Athanasia Mitropoulou, et al.
Published: (2022-08-01)

Thiol-Ene Reaction of Heparin Allyl Ester, Heparin 4-Vinylbenzyl Ester and Enoxaparin
by: Richard T. Taylor, et al.
Published: (2022-09-01)

Enoxaparin‐induced bullous hemorrhagic dermatosis at a distant location from the injection site
by: Abdulrahman F. Al‐Mashdali, et al.
Published: (2021-10-01)

The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility
by: Kogenta Nakamura, et al.
Published: (2007-06-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Heparin-induced thrombocytopenia: a rare presentation with skin necrosis
by: Filipa David, et al.
Published: (2023-10-01)

Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice
by: Justyna Swieton, et al.
Published: (2021-10-01)

Preferences and Practices of Brazilian Orthopedists for Thromboprophylaxis Techniques in Total Knee Arthroplasty: Survey Among Members of the Brazilian Society of Knee Surgery (SBCJ)
by: João Alberto Ramos Maradei-Pereira, et al.
Published: (2022-11-01)

Thromboprophylaxis in Abdominoplasty: Efficacy and Safety of a Complete Perioperative Protocol
by: Giovanni Francesco Marangi, et al.
Published: (2016-07-01)

Utilization profile of enoxaparin in hospitalized patients with Chronic Kidney Disease in southern Brazil
by: Carolina Araujo Cirne, et al.
Published: (2020-03-01)

Heparin versus enoxaparine for prevention of asymptomatic deep venous thrombosis after total knee arthroplasty
by: Adnan H. Hnoosh, et al.
Published: (2013-01-01)

Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit
by: Masoum Khoshfetrat, et al.
Published: (2020-05-01)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
by: Anna Matyjek, et al.
Published: (2021-12-01)